Stock 2496 WUHAN YZY BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Wuhan YZY Biopharma Co., Ltd.

Equities

2496

CNE1000063C4

Delayed Hong Kong S.E.
Other stock markets
 04:08:09 2024-07-16 am EDT 		5-day change 1st Jan Change
7.48 HKD 0.00% Intraday chart for Wuhan YZY Biopharma Co., Ltd. -7.08% -15.96%
May. 24 Wuhan Yzy Biopharma Presents Clinical Trial Data of Tumor Drug at Cancer Conference MT
May. 24 Wuhan YZY Biopharma Co., Ltd. Announces Phase II Study Data of M701 for the Treatment of Malignant Ascites Presented At the 2024 ASCO Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
WUHAN YZY BIOPHARMA CO., LTD. Stock Wuhan YZY Biopharma Co., Ltd.
 186M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.67B -
BIONTECH SE Stock BioNTech SE
 20.33B -
GENMAB A/S Stock Genmab A/S
 16.79B
  1. Stock Market
  2. Equities
  3. 2496 Stock
  4. Charts Wuhan YZY Biopharma Co., Ltd.
  5. Sector Chart